Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammasome activation and function in liver disease
Gyöngyi Szabó, Jan Petrášek
Nature Reviews Gastroenterology & Hepatology (2015) Vol. 12, Iss. 7, pp. 387-400
Closed Access | Times Cited: 514

Showing 1-25 of 514 citing articles:

Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman, Brent A. Neuschwander‐Tetri, Mary E. Rinella, et al.
Nature Medicine (2018) Vol. 24, Iss. 7, pp. 908-922
Open Access | Times Cited: 3354
NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice
Auvro R. Mridha, Alexander Wree, Avril A. B. Robertson, et al.
Journal of Hepatology (2017) Vol. 66, Iss. 5, pp. 1037-1046
Open Access | Times Cited: 874
The immunology of hepatocellular carcinoma
Marc Ringelhan, Dominik Pfister, Tracy O’Connor, et al.
Nature Immunology (2018) Vol. 19, Iss. 3, pp. 222-232
Closed Access | Times Cited: 865
Targeting hepatic macrophages to treat liver diseases
Frank Tacke
Journal of Hepatology (2017) Vol. 66, Iss. 6, pp. 1300-1312
Closed Access | Times Cited: 844
Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities
Yankai Wen, Joeri Lambrecht, Cynthia Ju, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 1, pp. 45-56
Open Access | Times Cited: 483
Apoptosis and necroptosis in the liver: a matter of life and death
Robert F. Schwabe, Tom Luedde
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 15, Iss. 12, pp. 738-752
Open Access | Times Cited: 474
Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation
David Porras, Esther Nistal, Susana Martínez‐Flórez, et al.
Free Radical Biology and Medicine (2016) Vol. 102, pp. 188-202
Closed Access | Times Cited: 442
Innate Immunity and Inflammation in NAFLD/NASH
Marco Arrese, Daniel Cabrera, Alexis M. Kalergis, et al.
Digestive Diseases and Sciences (2016) Vol. 61, Iss. 5, pp. 1294-1303
Open Access | Times Cited: 441
SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation
Pan Pan, Miaomiao Shen, Zhenyang Yu, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 417
Non-alcoholic fatty liver disease
Brent A. Neuschwander‐Tetri
BMC Medicine (2017) Vol. 15, Iss. 1
Open Access | Times Cited: 416
Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice
Bing Xu, Mingzuo Jiang, Yi Chu, et al.
Journal of Hepatology (2017) Vol. 68, Iss. 4, pp. 773-782
Closed Access | Times Cited: 354
The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma
Romain Donné, Amaia Lujambio
Hepatology (2022) Vol. 77, Iss. 5, pp. 1773-1796
Closed Access | Times Cited: 335
Role of the inflammasome in acetaminophen-induced liver injury and acute liver failure
Benjamin L. Woolbright, Hartmut Jaeschke
Journal of Hepatology (2016) Vol. 66, Iss. 4, pp. 836-848
Open Access | Times Cited: 334
Adaptive immunity: an emerging player in the progression of NAFLD
Salvatore Sutti, Emanuele Albano
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 17, Iss. 2, pp. 81-92
Open Access | Times Cited: 311
Interleukin‐1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Herbert Tilg, Alexander R. Moschen, Gyöngyi Szabó
Hepatology (2016) Vol. 64, Iss. 3, pp. 955-965
Open Access | Times Cited: 282
Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia
Xue Li, Juntao He, Ning Gao, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 263
Inflammasomes in the gastrointestinal tract: infection, cancer and gut microbiota homeostasis
Si Ming Man
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 15, Iss. 12, pp. 721-737
Open Access | Times Cited: 257
Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction
Cornelius Engelmann, J. J. Clariá, Gyöngyi Szabó, et al.
Journal of Hepatology (2021) Vol. 75, pp. S49-S66
Open Access | Times Cited: 256
Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism
Sander Lefere, Frank Tacke
JHEP Reports (2019) Vol. 1, Iss. 1, pp. 30-43
Open Access | Times Cited: 237
The Role of Monocytes and Macrophages in Acute and Acute-on-Chronic Liver Failure
Evangelos Triantafyllou, Kevin Woollard, Mark McPhail, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 235
Cell Death in Liver Diseases: A Review
Layla Shojaie, Andrea Iorga, Lily Dara
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9682-9682
Open Access | Times Cited: 224
Pathophysiology and Management of Alcoholic Liver Disease: Update 2016
Felix Stickel, Christian Datz, Jochen Hampe, et al.
Gut and Liver (2017) Vol. 11, Iss. 2, pp. 173-188
Open Access | Times Cited: 222
Mechanisms of bile acid mediated inflammation in the liver
Man Li, Shi‐Ying Cai, James L. Boyer
Molecular Aspects of Medicine (2017) Vol. 56, pp. 45-53
Open Access | Times Cited: 222
Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease
Yamei Duan, Xiongfeng Pan, Jiayou Luo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 222
Mouse models of nonalcoholic steatohepatitis in preclinical drug development
Henrik H. Hansen, Michael Feigh, Sanne Skovgård Veidal, et al.
Drug Discovery Today (2017) Vol. 22, Iss. 11, pp. 1707-1718
Open Access | Times Cited: 218
Page 1 - Next Page

Scroll to top